Shenqi Fuzheng injection restores the sensitivity to gefitinib in non-small cell lung cancer by inhibiting the IL-22/STAT3/AKT pathway-Reference-Cited by-同舟云学术

Shenqi Fuzheng injection restores the sensitivity to gefitinib in non-small cell lung cancer by inhibiting the IL-22/STAT3/AKT pathway

Author:

Wang Jiali¹^ORCID,He Xianhai¹,Jia Zhirong¹,Yan Aiwen²,Xiao Kang¹,Liu Shuo¹,Hou Mengjun¹,Long Yaling¹,Ding Xuansheng¹³

Affiliation:

1. School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China

2. Jiangsu Food & Pharmaceutical Science College, Jiangsu Food Science College, Huanan, China

3. Precision Medicine Laboratory, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China

Funder

China Pharmaceutical University Double First-Rate Construction Plan

Publisher

Informa UK Limited

Subject

Complementary and alternative medicine,Drug Discovery,Pharmaceutical Science,Pharmacology,Molecular Medicine,General Medicine

Link

Reference47 articles.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献